Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using sonazoid: Comparison with dynamic computed tomography

Journal of Clinical Ultrasound

Volumn 38, Issue 4, 2010, Pages 182-189

  Shiozawa, Kazue ^a   Watanabe, Manabu ^a   Takayama, Ryuji ^a   Takahashi, Masayoshi ^a   Wakui, Noritaka ^a   Iida, Kazunari ^a   Sumino, Yasukiyo ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

Contrast enhanced ultrasonography; Hepatocellular carcinoma; Local recurrence; Sonazoid

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERRIC ION; IRON; NYCOMED; OXIDE;

AGED; AREA UNDER THE CURVE; ARTICLE; CATHETER ABLATION; CHEMOEMBOLIZATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EVALUATION; FEMALE; HUMAN; IMAGE ENHANCEMENT; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; FEMALE; FERRIC COMPOUNDS; HUMANS; IMAGE ENHANCEMENT; IRON; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; OXIDES; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951861790     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.20685     Document Type: Article

References (32)

1. Hasegawa K, Makuuchi M, Takayama T, et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008; 49:589.
2. Lencioni RA, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235.
3. Kudo M, Okanoue T. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007;72:2.
4. Llovet JM, Real MI, MT X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002;359:1734.
5. Veltri A, Moretto P, Doriguzzi A, et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 2006;16:661.
6. Chopra S, Dodd GD 3rd, Chintapalli KN, et al. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol 2001;177:381.
7. Lim HK, Choi D, Lee WJ, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001;221:447.
8. Sironi S, Livraghi T, Meloni F, et al. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol 1999;173:1225.
9. Choi D, Lim HK, Kim SH, et al. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J Ultrasound Med 2002;21:391.
10. Minami Y, Kudo M, Kawasaki T, et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. AJR Am J Roentgenol 2003;180:703.
11. Choi D, Lim HK, Lee WJ, et al. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 2003;22:1163.
12. Wen YL, Kudo M, Zheng RQ, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phaseinversion harmonic sonography. AJR Am J Roentgenol 2003;181:57.
13. Kim SH, Lee JM, Lee JY, et al. Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: receiver operating characteristic analysis. AJR Am J Roentgenol 2005;184:1077.
14. Kim CK, Choi D, Lim HK, et al. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005;56:66.
15. Forsberg F, Piccoli CW, Liu JB, et al. Hepatic tumor detection, MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase. Radiology 2002;222:824.
16. Kindberg GM, Tolleshaug H, Roos N, et al. Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells dose not reduce the ability of liver to phagocytose or degrade albumin micro-spheres. Cell Tissue Res 2003;312:49.
17. Yanagisawa K, Moriyasu F, Miyahara T, et al. Phagocytosis of ultrasound contrast agent micro-bubbles by Kupffer cells. Ultrasound Med Biol 2007;33:318.
18. Watanabe R, Matsumura M, Munemasa T, et al. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol 2007;42:643.
19. Nakano H, Ishida Y, Hatakeyama T, et al. Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metas-tases. World J Gastroenterol 2008;14:3207.
20. Hatanaka K, Kudo M, Minami Y, et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid Intervirol 2008; 51:61.
21. Luo W, Numata K, Morimoto M, et al. Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods. AJR Am J Roentgenol 2009;192:165.
22. Xia Y, Kudo M, Minami Y, et al. Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas: the usefulness of sonazoid-enhanced harmonic sonography. Oncology 2008;75:99.
23. Shiozawa K, Watanabe M, Wakui N, et al. Risk factors for the local recurrence of hepatocellular carcinoma after single-session percutaneous radiofrequency ablation with a single electrode insertion. Mol Med Rep 2009;1:89.
24. Kudo M, Hatanaka K, Maekawa K. Sonazoid-enhanced ultrasound in the diagnosis and treatment of hepatic tumors. J Med Ultrasound 2008;16:130.
25. Zhao H, Yao JL, Wang Y, et al. Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning. World J Gastroenterol 2007;13:1252.
26. Seki T, Tamai T, Ikeda K, et al. Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region. Eur J Gastroenterol Hepatol 2001;13:291.
27. Ruzzenente A, Manzoni GD, Molfetta M, et al. Rapid progression of hepatocellular carcinoma after radiofrequency ablation. World J Gastroenterol 2004;10:1137.
28. McGahan JP, Dodd GD III. Radiofrequency ablation of the liver: Current status. AJR Am J Roentgenol 2001;176:3.
29. Shiozawa K, Watanabe M, Wakui N, et al. Analysis of patients with tumor seeding after percutaneous radiofrequency ablation of hepatocellular carcinoma. Mol Med Rep 2008;1:851.
30. Yanagisawa K, Moriyasu F, Miyahara T, et al. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007;33:318.
31. Numata K, Tanaka K, Kiba T, et al. Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings. J Ultrasound Med 2001;20:89.
32. Youk JH, Lee JM, Kim CS. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging. J Ultrasound Med 2003;22:911.